Procedure Deep-Dive · November 17, 2026
Hereditary Hemorrhagic Telangiectasia (HHT) and Cosmetic Procedures: Nosebleeds, Red Spots on the Lips and Face, Lasers, Rhinoplasty, Lung AVMs, Anemia, and Bevacizumab
HHT is an inherited blood vessel disorder that shows up as frequent nosebleeds and small red spots on the lips, tongue, face, and fingertips. The spots are what bring many adults to a cosmetic practice. The hidden vessels in the lungs, brain, liver, and gut are what should decide whether, where, and how anything elective happens. Here is what lasers can do for the spots, why rhinoplasty is a different operation in HHT, and what screening, iron, antibiotics, and IV filters have to do with a facelift or a tummy tuck.
By The Editorial Desk
19 min read

He is 46 and wants two things done. The first is "the red dots": a dozen or so pinpoint and pinhead-sized spots on his lips, the tip of his tongue, and two of his fingertips, plus a few on his cheeks that have multiplied over the last ten years. The second is his nose. He has a dorsal hump he has always disliked, and he wonders whether a rhinoplasty might also help with the nosebleeds he has had since childhood, which now come several times a week. His mother had the same nosebleeds. So did his grandfather, who died of a stroke in his fifties. He has never been given a diagnosis. He takes iron tablets because his primary care doctor told him he was "a little anemic."
Nothing in that history is unusual for a cosmetic consultation, taken one item at a time. Taken together, it describes a textbook case of hereditary hemorrhagic telangiectasia, usually called HHT and sometimes still called Osler-Weber-Rendu syndrome. The red spots are real and can often be treated well. But they are the visible edge of a condition that can also place abnormal connections between arteries and veins in the lungs, brain, liver, and digestive tract, and those connections are what turn a routine IV line, a dental cleaning, or a nasal packing into a planning problem. This piece walks through what HHT is, how the hidden vessels change elective care, what lasers and camouflage can do for the visible spots, why the nose deserves special respect, and what a sensible anesthesia and body-contouring plan looks like.
What HHT is, and why red spots on the lips are a clue
The short answer: HHT is an inherited disorder of blood vessel development, passed down in a dominant pattern, in which small vessels form direct artery-to-vein connections that are fragile and bleed easily, showing up as recurrent nosebleeds and small red spots on the lips, tongue, face, and fingers, and sometimes as larger hidden malformations in internal organs.
HHT affects roughly one in every five thousand people, a figure that varies by region and is almost certainly an undercount, because many families live with the nosebleeds for generations without a name for them. It is inherited in an autosomal dominant pattern, which means each child of an affected parent has a one in two chance of carrying the gene, and it affects men and women equally. Most cases trace to mutations in one of two genes, ENG (HHT type 1) and ACVRL1, also called ALK1 (HHT type 2). A smaller group carries a mutation in SMAD4, which causes a combined syndrome of HHT and juvenile polyposis, with a higher risk of colon polyps and colon cancer. All of these genes sit in the same signaling pathway that tells developing blood vessels how to form the fine capillary network between arteries and veins.
When that network fails to form properly, an artery connects directly to a vein. In the skin and the lining of the nose and mouth, these direct connections are tiny and called telangiectasias. In larger organs they can be big enough to be called arteriovenous malformations, or AVMs. Because these vessels skip the capillary bed, they carry blood at arterial pressure in a thin-walled channel, which is why they bleed so readily and why they behave differently from the ordinary broken capillaries of sun damage or rosacea.
Doctors diagnose HHT clinically using the Curacao criteria, published in 2000 and still used by the international guidelines. There are four:
- Nosebleeds (epistaxis). Spontaneous and recurrent. More than nine in ten people with HHT have them, often starting in childhood or the teenage years, and they tend to become more frequent with age.
- Telangiectasias at characteristic sites. Multiple small red spots on the lips, oral cavity, tongue, fingers, and nose. These usually appear later than the nosebleeds, often in the twenties through forties, and increase in number over time.
- Internal AVMs or telangiectasias. In the lungs, brain, liver, spine, or gastrointestinal tract.
- A first-degree relative with HHT.
Three criteria make the diagnosis definite, two make it possible, and fewer than two make it unlikely. Genetic testing can confirm the diagnosis in most families once the specific mutation is known, and it is especially useful for children and young adults who have not yet developed the visible signs.
The reason this matters to a cosmetic practice is that the characteristic spots are exactly what brings people in. The spots of HHT are typically one to three millimeters, bright red to purple, flat or slightly raised, and they blanch with pressure. They cluster on the lips, the tip and sides of the tongue, the inside of the cheeks, the fingertips, and the face, particularly the nose and cheeks. That pattern is different from several look-alikes:
- Broken capillaries from sun damage or rosacea. Fine, branching red lines on the cheeks and around the nose, rather than discrete dots on the lips and fingertips. These are covered in the piece on facial redness and vascular lasers.
- Spider angiomas. A central red dot with radiating legs, common in pregnancy and in liver disease. Many of them in an adult man should prompt a look at the liver, as discussed in the piece on fatty liver disease and cosmetic surgery.
- Mat telangiectasias of limited scleroderma. Flat, square-ish red patches on the face, lips, and hands, often with tight skin or Raynaud's. The piece on scleroderma and cosmetic surgery covers that pattern.
- Cherry angiomas. Small, dome-shaped red bumps on the trunk that become common with age and are harmless.
- Port-wine stains and venous lakes. A continuous patch or a soft blue bump, not a scatter of pinpoint dots. Capillary malformations are discussed in the piece on port-wine stains in adults.
The single most useful question a clinician can ask a patient with red dots on the lips is: "Do you get nosebleeds, and does anyone in your family?" A yes to both should pause the laser appointment until someone has considered HHT.
The hidden vessels: lungs, brain, liver, and gut, and why screening comes first
The short answer: Many people with HHT have AVMs in the lungs, and a smaller share have them in the brain, liver, or gut, and because a lung AVM can let a clot, an air bubble, or bacteria bypass the lungs and travel to the brain, international guidelines recommend screening every adult with HHT before any of this becomes an emergency, which in practice means before elective surgery.
The Second International Guidelines for the Diagnosis and Management of HHT, published in the Annals of Internal Medicine in 2020 by an expert panel convened through the Cure HHT foundation, set out the screening that most HHT centers follow. Each organ matters to cosmetic planning in a different way.
Lungs. Pulmonary AVMs are found in roughly a third to a half of people with HHT, more often in type 1 (ENG) than type 2. A healthy lung acts as a filter: small clots, air bubbles, and bacteria that enter a vein are trapped in the lung's capillaries. A pulmonary AVM is a gap in that filter. Material that enters a vein can pass straight through to the arterial circulation and lodge in the brain, causing a stroke, or seed an infection that becomes a brain abscess. Large pulmonary AVMs can also lower blood oxygen, sometimes noticeably more when the person is sitting or standing than when lying down, because the malformations tend to sit in the lower lungs. The guidelines recommend screening adults with a contrast (bubble) echocardiogram, and treating AVMs above a certain size with embolization, a catheter procedure in which an interventional radiologist plugs the feeding artery. Embolization is not surgery on the lung, recovery is usually quick, and treated AVMs need periodic follow-up imaging because some reopen.
Brain. Cerebral AVMs occur in roughly one in ten people with HHT, again more often in type 1. Most never bleed, but a bleed can be devastating, and the guidelines recommend a screening MRI of the brain in adults with HHT. A brain AVM may also explain seizures or headaches. Whether a known brain AVM should be treated is an individual decision made by neurosurgeons and neuroradiologists, and it can affect what blood pressure targets an anesthesiologist will want during an operation.
Liver. Liver vascular malformations are very common on imaging and usually cause no symptoms. When large, they can strain the heart (high-output heart failure) or affect the bile ducts. The practical point for any surgical team is that liver biopsy should be avoided in someone with suspected HHT liver involvement, and that a patient with a heart strained by liver AVMs is not a straightforward candidate for large-volume procedures. Heart limitations and fluid shifts are discussed in the piece on heart failure and cosmetic surgery.
Gut. Telangiectasias in the stomach and small bowel are common and tend to bleed slowly, often starting after fifty. Combined with nosebleeds, that slow loss is why so many adults with HHT have chronic iron deficiency anemia. The guidelines recommend that all adults with HHT have their hemoglobin and ferritin checked, and that anemia out of proportion to the nosebleeds prompt an evaluation of the gut. People with SMAD4 mutations need colonoscopy screening for polyps.
"The red dots on the lip are the part of HHT a patient can see. The pulmonary AVM is the part an anesthesiologist needs to know about, and no amount of skill with a laser substitutes for a bubble echo done beforehand."
For an adult who already has an HHT diagnosis, the question at a cosmetic consultation is not whether they have been screened in theory but whether the results are on paper: the date of the last bubble echo, whether any pulmonary AVMs were found and embolized, the brain MRI result, the most recent hemoglobin and ferritin, and the name of the HHT specialist. For an adult like the man in the opening paragraph, who has never been diagnosed, the right next step is a referral to an HHT Center of Excellence, of which there are a few dozen in North America and more internationally, and a postponed procedure. That delay is measured in weeks to a few months. The risk it avoids is a stroke.
Treating the visible spots: lasers, sclerotherapy, camouflage, and fillers
The short answer: The small telangiectasias of HHT on the face, lips, and fingers usually respond well to vascular lasers, with the honest caveat that new spots keep appearing over a lifetime, so treatment is maintenance rather than cure, and needle-based procedures on the lips require more care than usual.
The same vascular lasers used for facial redness work on HHT skin and lip spots. The pulsed dye laser (595 nanometers) and the potassium titanyl phosphate (KTP) laser (532 nanometers) target hemoglobin and are the usual choices for small, flat spots. The long-pulsed neodymium:YAG laser (1064 nanometers) reaches deeper and is used for thicker or more raised lesions, with a higher risk of scarring if the settings are wrong. Published case series from HHT centers and dermatology groups report that most cutaneous and lip telangiectasias lighten substantially or disappear with one to a few sessions. Intense pulsed light is sometimes used for clusters on the face. Electrocautery can treat a single stubborn spot but tends to leave more of a mark than a laser.
What patients with HHT should expect, and what makes them different from someone treating rosacea:
- Good response per spot, but new spots keep coming. HHT telangiectasias increase in number with age. A clean result at 40 will not stay clean at 50 without touch-up sessions. Patients should budget for maintenance every year or two.
- Bleeding is part of the conversation. Lip and fingertip spots can bleed when bumped, bitten, or treated aggressively. A laser that ruptures a vessel rather than closing it can cause brisk bleeding that needs pressure. Practices that treat HHT regularly usually have a plan for this, and the patient should not be on aspirin or other blood thinners unless a doctor has a reason for them.
- Bruising after pulsed dye laser. As with any vascular laser at effective settings, treated spots may turn purple for a week or two. The piece on arnica and bromelain for bruising explains why those supplements do less than their marketing suggests, and in HHT they are not a substitute for a treatment plan that limits bleeding in the first place.
- Darker skin needs test spots. The 532-nanometer wavelength in particular is also absorbed by melanin, raising the risk of pigment changes in medium to dark skin tones.
- Fingertip spots are a medical problem too. Recurrent bleeding from a fingertip lesion is a reasonable reason to treat it even if it is not a cosmetic concern, and insurance sometimes covers it on that basis.
The tongue and the inside of the mouth are different territory. Oral telangiectasias that bleed are usually treated by an ENT surgeon, oral surgeon, or HHT specialist rather than in a cosmetic laser room, sometimes in an operating room.
Lip fillers deserve particular thought. A lip full of telangiectasias is a lip full of fragile, high-pressure vessels just under the surface. Every needle or cannula pass carries more risk of puncturing one, with more bruising and occasionally a bleed that needs firm pressure. There is no evidence that HHT raises the rate of the dreaded filler complication, intravascular injection, but the general principles described in the piece on filler vascular occlusion still apply, and an injector who cannot see the spots clearly because of swelling or bleeding is working with less information. Reasonable precautions include treating the most prominent lip spots with laser first and letting them heal, mapping and avoiding visible vessels, using a cannula where appropriate, and keeping the volume modest. The same logic applies to lip lifts and other perioral surgery, which cut directly through this tissue.
Camouflage makeup works well for the facial spots and is the lowest-risk option of all. Many people with HHT use a green-tinted corrector under foundation, the techniques of which are described in the piece on makeup camouflage after procedures. Cosmetic tattooing over the lip line is a poor choice: the needle repeatedly punctures the same fragile vessels, and the pigment complicates any future laser treatment of the spots.
The nose: nosebleeds, rhinoplasty, septoplasty, packing, and what actually helps
The short answer: A cosmetic rhinoplasty is possible in some people with well-controlled HHT, but it should be planned with an ENT surgeon who treats HHT, because the nasal lining is where HHT bleeds most, a rhinoplasty will not stop nosebleeds, and routine steps like septoplasty, nasal packing, and nasal intubation can cause serious bleeding.
The nosebleeds of HHT come from telangiectasias in the lining of the nose, mostly the front of the septum and the side walls. They are not caused by the shape of the nose, so reshaping the bony and cartilage framework does nothing to prevent them. If anything, the surgery adds a risk: incisions inside the nose, elevation of the lining off the septum, and swelling all disturb tissue that already bleeds at the slightest provocation. An honest surgeon will tell a patient with HHT that a rhinoplasty is a cosmetic operation with a bleeding risk, not a nosebleed treatment.
Several standard rhinoplasty steps need rethinking in HHT:
- Septoplasty. Straightening the septum means lifting its lining, which is exactly where HHT lesions sit. Unless there is a strong functional reason, many HHT surgeons avoid it. When the airway genuinely needs work, the indications discussed in the piece on functional rhinoplasty should be weighed carefully against the bleeding risk.
- Nasal packing. The 2020 guidelines specifically advise that if packing is needed in HHT, it should be low-pressure, lubricated, or absorbable, because removing ordinary packing tears off the healing lining and restarts the bleeding. Many HHT surgeons avoid packing and splints that press on the septum entirely.
- Nasal intubation, nasal tubes, and dry oxygen. An anesthesiologist should not pass a breathing tube or a stomach tube through the nose of someone with HHT, and supplemental oxygen through a nasal cannula should be humidified, because dry air cracks the lining. These points belong in the anesthesia plan in writing.
- Recovery rules. The ordinary instructions in the piece on rhinoplasty recovery rules (no nose blowing, sleep elevated, avoid straining) matter more than usual. Gentle saline and a lubricating ointment inside the nostrils are standard parts of daily HHT care anyway.
- Septal perforation. People with HHT who have had repeated cautery or laser treatment inside the nose sometimes already have a hole in the septum, which changes what a rhinoplasty can support. The problem is described in the piece on septal perforation and saddle nose.
Nonsurgical "liquid rhinoplasty" with filler has its own concerns in HHT. The skin over the nose often carries telangiectasias, and the nose is already one of the higher-risk zones for filler occlusion. A patient who wants it should hear those risks plainly.
What actually helps the nosebleeds is a separate treatment ladder, managed by ENT surgeons and hematologists who know HHT. The 2020 guidelines describe it roughly in this order: moisturizing the nasal lining with saline and ointments; oral tranexamic acid, a medication that slows clot breakdown and is discussed in a surgical context in the piece on tranexamic acid in cosmetic surgery; targeted treatments of the lesions inside the nose with lasers, radiofrequency, or sclerotherapy; surgical options such as septodermoplasty, in which the fragile lining is replaced with a skin graft; and, for the most severe cases, closure of the nostrils, known as Young's procedure. For people with severe bleeding and transfusion-dependent anemia, the guidelines also recommend considering intravenous bevacizumab, a drug that blocks vascular endothelial growth factor (VEGF), the signal that drives abnormal vessel growth. A randomized trial published in the New England Journal of Medicine in 2024 found that pomalidomide, a drug related to thalidomide, reduced nosebleed severity in HHT, and it is now part of the specialist conversation.
Those systemic drugs matter for surgery. Bevacizumab impairs wound healing, and its labeling warns about wound complications. Cancer centers, which use it far more often, generally avoid elective surgery for several weeks after a dose and wait for incisions to heal before resuming it. Anyone on bevacizumab for HHT who is considering an elective procedure should expect the HHT team and the surgeon to agree on a timing window together. Pomalidomide and thalidomide raise the risk of blood clots, which interacts directly with the clot prevention planning discussed below.
Anesthesia, iron, antibiotics, clots, and body procedures
The short answer: With screening done and the anemia corrected, people with HHT can have most cosmetic procedures, but the plan should include iron repletion, filters that trap air bubbles on every IV line, antibiotics before procedures that can introduce bacteria into the blood if lung AVMs are present or have not been excluded, careful blood pressure control if there is a brain AVM, and a balanced approach to clot prevention.
Iron and anemia. Chronic blood loss leaves many adults with HHT iron deficient, sometimes severely, even when their hemoglobin looks borderline. Operating on an anemic patient raises the chance of transfusion and slows recovery, as explained in the piece on anemia and blood loss around cosmetic surgery. Oral iron often cannot keep up with HHT losses, and intravenous iron is commonly used. A few weeks of planning to bring the ferritin and hemoglobin up is time well spent, and it matters more for procedures with real blood loss, such as a tummy tuck, a breast reduction, or large-volume liposuction, than for a laser session.
IV filters. Because a pulmonary AVM lets air in a vein reach the brain, the guidelines advise that people with known or suspected lung AVMs have air filters on their IV lines and that staff take care to keep bubbles out of syringes and tubing. This costs almost nothing and is easy to forget in an outpatient surgery center that rarely sees HHT, which is why it belongs in writing on the anesthesia plan.
Antibiotics. The same filter gap explains the brain abscess risk. The 2020 guidelines recommend antibiotic prophylaxis before dental procedures and other procedures with a risk of bacteria entering the blood for people with pulmonary AVMs, and for those who have not yet been screened. Many cosmetic operations already include a single preoperative antibiotic dose, as covered in the piece on antibiotics after cosmetic surgery, but a person with HHT and lung AVMs should also have this covered for dental cleanings and other minor procedures. The same principle appears, for a different reason, in the piece on dental work after breast implants.
Oxygen and positioning. Someone with untreated or residual lung AVMs may start the day with lower oxygen saturation than a typical patient, and it can fall further when upright. That matters for sedation, for recovery-room monitoring, and for a patient who will spend the first days after surgery sitting propped up. The anesthesia plan, described more generally in the piece on choosing an anesthesia plan, should be built around the patient's baseline numbers, not the usual defaults.
Brain AVMs and blood pressure. A known, untreated brain AVM is a reason for the anesthesiologist to avoid surges in blood pressure, during waking up, for example. It is also a reason to think hard about procedures that involve straining or long periods head-down. A neurosurgeon's opinion belongs in the file.
Clots and blood thinners. People with HHT are not protected from blood clots, and iron deficiency itself appears to raise the risk of venous clots somewhat. The guidelines note that HHT is not an absolute contraindication to anticoagulants or antiplatelet drugs when there is a real indication, though they increase bleeding. For body procedures, the risk assessment for clots described in the piece on blood clots after plastic surgery still applies, and the decision about medication-based clot prevention should weigh the nosebleed and gut bleeding history alongside the usual factors. Mechanical measures such as compression devices and early walking carry no bleeding risk and are standard. Someone already on a blood thinner for another condition faces the questions laid out in the piece on blood thinners before cosmetic surgery. Supplements that affect bleeding, such as fish oil, vitamin E, and ginkgo, are worth stopping in advance, as described in the supplement stop list.
Pregnancy. Pregnancy enlarges pulmonary AVMs and raises the risk of bleeding from them, and the guidelines treat pregnancy in HHT as high risk. Anyone planning a family should have lung AVMs screened and treated beforehand. For cosmetic timing, that is one more reason to sequence body procedures after pregnancy plans are settled.
Choosing the team. Most cosmetic surgeons will see few patients with HHT in a career, and that is fine as long as they know what they do not know. The reasonable approach is coordination: the HHT center provides the screening results and recommendations, the surgeon plans the operation, and the anesthesiologist reads both before the day of surgery. A practice that waves off the diagnosis as "just nosebleeds," or a med spa that offers to laser the lip spots without asking a single question about family history, is a signal to slow down. The supervision questions raised in the piece on who is holding the device at a med spa apply here with extra force. When the advice from different practices conflicts, a second opinion from a surgeon who works with an HHT center is worth the time.
The honest summary
HHT is an inherited vascular disorder affecting roughly one in five thousand people. Its signature is a combination of recurrent nosebleeds, small red spots on the lips, tongue, face, and fingertips, and a family history of the same. Many adults reach a cosmetic practice because of the spots, and some have never been diagnosed. A clinician who asks about nosebleeds and family history before treating red dots on the lips can change the course of a patient's life.
The hidden part of HHT matters most for elective care. Lung AVMs can let clots, air, and bacteria reach the brain, brain AVMs can bleed, liver AVMs can strain the heart, and gut telangiectasias cause chronic anemia. International guidelines recommend screening every adult with a bubble echocardiogram and a brain MRI, treating significant lung AVMs with embolization, and checking hemoglobin and ferritin. For anyone with HHT, those results should be on paper before a cosmetic procedure is scheduled.
The visible spots usually respond well to vascular lasers, but new ones appear over time, so maintenance is part of the plan. Lip fillers and perioral surgery are possible with care. Camouflage makeup is the gentlest option, and cosmetic tattooing over lip spots is a poor one. Rhinoplasty will not stop nosebleeds, and septoplasty, ordinary nasal packing, and tubes through the nose can cause serious bleeding, so any nasal surgery belongs in the hands of a team that knows HHT. Nosebleed treatment is its own ladder, from moisturizers and tranexamic acid through procedures to bevacizumab and newer drugs, and those medications affect when surgery can be timed.
With screening done, iron restored, IV filters and antibiotics in place, and the nose and blood pressure respected, most people with HHT can have the aesthetic procedures they want. The goal is not to avoid treatment. It is to make sure the people treating the spots know about the vessels no one can see.